Piper was looking for 13-14M in sales I believe. This is quite possible. the run rate for working capital exceeds the previous 2 quarters by about $4M. If most of this is an increase in A/R then we can get to that number. We will soon find out. I am more interested in Guidance going forward from Hastings.
I recall reading somewhere that Hastings was an Orbimed pick. Not sure why you say he was ousted from INCY. It was clearly mentioned on his last conference call was that it was his choice and they were sad to have him leave but that he graciously agreed to stay one month to train the incoming CFO. This was planned. After 11 years at INCY, why wouldn't he want a vacation before coming to UNIS?